BSIM Therapeutics

Société

À propos de votre organisation / profil

Accelerator Application

BSIM Therapeutics is a biotech company focused on the design of organ-targeted, high-quality drug candidates for the treatment of life-threatening transthyretin-mediated amyloidoses (ATTR). We work closely with patients and physicians to understand and answer to multiple clinical manifestations of these pathologies which represent unmet medical needs.